Elevance Health Inc.
HealthcareNYSE:ELV · New York Stock Exchange
+$4.89 today
Vol 1.23M · Avg 1.73M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+7.28%
Period High
$422.71
Period Low
$269.01
Latest
$404.07
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$130.09B
GSK plc
NYSE:GSK
$106.31B
Cigna Corporation
NYSE:CI
$78.83B
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$63.06B
Cencora, Inc.
NYSE:COR
$54.80B
Becton, Dickinson and Company
NYSE:BDX
$52.98B
Humana Inc.
NYSE:HUM
$45.53B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.24B
Zoetis Inc.
NYSE:ZTS
$33.36B
GE HealthCare Technologies Inc.
NASDAQ:GEHC
$29.65B
What is the latest ELV filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does ELV have?
Intrinsic Alpha currently shows 20 recent filings for ELV.
Explore More
Continue the stock analysis
Jump to another research area for this company.